FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely, to cardiology, and is intended for treating familial hypercholesterolemia in a subject in need thereof, including administration of a combination with fixed doses of ETC-1002 and ezetimibe to said subject, wherein the combination with fixed doses comprises 180 mg ETC-1002 and 10 mg ezetimibe. The group of inventions also relates to an application of the combination with fixed doses containing 180 mg ETC-1002 and 10 mg ezetimibe for treating familial hypercholesterolemia.
EFFECT: joint activity of a combination of two therapeutic agents, leading to lower levels of LDL-C and favourable results of clinical treatment.
18 cl, 4 tbl, 3 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FIXED COMBINATIONS AND COMPOSITIONS CONTAINING ETC1002 AND ONE OR MORE STATINS, AND METHODS FOR TREATMENT OR REDUCTION IN RISK OF DEVELOPMENT OF CARDIOVASCULAR DISEASE | 2016 |
|
RU2765218C2 |
| METHODS OF TREATING PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR DISEASES HAVING HYPERCHOLESTEROLEMIA | 2015 |
|
RU2723018C2 |
| METHODS OF TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) | 2015 |
|
RU2735521C2 |
| METHODS FOR TREATMENT OF HYPERLIPIDEMIA IN PATIENTS WITH DIABETES BY INJECTION OF PCSK9 INHIBITOR | 2018 |
|
RU2772712C2 |
| TREATING WITH ANTI-PCSK9 ANTIBODIES | 2012 |
|
RU2576034C2 |
| COMPOSITIONS IN FIXED DOSES | 2018 |
|
RU2810163C2 |
| METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2010 |
|
RU2505292C2 |
| HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS | 2012 |
|
RU2603481C2 |
| METHODS OF TREATMENT OF HYPERTRIGLYCERIDEMIA | 2019 |
|
RU2797547C2 |
| METHODS OF TREATMENT OF HYPERTRIGLYCERIDEMIA | 2013 |
|
RU2686315C2 |
